Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

United States Hepatitis C Market and Competitive Landscape Highlights Report 2010-2020 - Research and Markets

Research and Markets
Posted on: 05 Oct 16

Research and Markets has announced the addition of the "US Hepatitis C Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Hepatitis C Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Hepatitis C pipeline products, Hepatitis C epidemiology, Hepatitis C market valuations and forecast, Hepatitis C products sales and competitive landscape in the US.

The research is classified into nine sections - Hepatitis C overview including etiology, pathophysiology, and diagnosis, Hepatitis C treatment options, Hepatitis C pipeline products, Hepatitis C market analysis comprising of Hepatitis C epidemiology, key products marketed for Hepatitis C, market valuations and forecast, products sales and market shares.

Research Scope:

  • Hepatitis C Pipeline: Find out the products in clinical trials for the treatment of Hepatitis C by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Hepatitis C Epidemiology: Find out the number of patients diagnosed (prevalence) with Hepatitis C in the US
  • Hepatitis C Products: Identify key products marketed and prescribed for Hepatitis C in the US, including trade name, molecule name, and company
  • Hepatitis C Product Sales: Find out the sales revenues of Hepatitis C products, both branded and generics, in the US
  • Hepatitis C Market Valuations: Find out the market size for Hepatitis C products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Hepatitis C Products Market Share: Find out the market shares for key Hepatitis C products in the US

Key Topics Covered:

  1. Disease Overview
  2. Hepatitis C Treatments
  3. Hepatitis C Pipeline
  4. US Hepatitis C Epidemiology
  5. Marketed Drugs for Hepatitis C in US
  6. US Hepatitis C Market Size
  7. US Hepatitis C Products Sales
  8. US Hepatitis C Market Competitive Landscape
  9. US Hepatitis C Market Forecast

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 05/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.